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The use of macrolides seems to differ from one country 
to another. I believe that the drugs have been used for 
different purposes in each country. For example, the 
use of macrolides in japan is different from that in 
France, where their application is more widespread. 
Here we would like to discuss the positioning of 
niacrolides in respiratory tract infections from an 
academic point of view. In discussing macrolide efficacy 
for acute respiratory tract infections in the past, we have 
simply focused on their function as antibiotics. How- 
ever, in assessing their efficacy in chronic respiratory 
tract infection we need to pay attention to another 
aspect besides their antimicrobial function. In Japan, a 
large number of studies have been already conducted to 
elucidate macrolide function in diffke panbronchio- 
litis, a chronic respiratory disease which is particularly 
prevalent in the Japanese population. So it may be 
possible to apply macrolides to new therapeutic 
domains, at  least in Japan. 
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